Back to top

MTN-042B was designed and conducted as sub-study of DELIVER (MTN-042) to provide the basis for comparison needed to evaluate the safety of PrEP and the dapivirine ring during pregnancy. MTN-042B involved a review of more than 10,000 medical charts at maternity hospitals and clinics in the same communities where DELIVER is taking place, providing important insight about pregnancy and neonatal outcomes in these communities as well as the frequency with which different complications occur. (see also the DELIVER study.)

10,000-plus medical charts provides comparator for HIV prevention study in pregnant women
31-March-2021

Fact Sheet: The MTN-042B Sub-study of DELIVER (MTN-042)
31-March-2021

See Also

MTN-042B Protocol

MTN-042B Study Page

DELIVER (MTN-042) Study Page